Catheter Precision, Inc. announced on June 9, 2025, the receipt of its first purchase order for the VIVO product from Sweden. The order came from Sahlgrenska University Hospital, which is the largest hospital in Sweden.
Sahlgrenska University Hospital is also recognized as a highly influential center for ventricular tachycardia (VT) in Scandinavia. This purchase order marks a significant entry for VIVO into a key European market.
The VIVO system is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure. This adoption by a leading institution like Sahlgrenska University Hospital demonstrates growing international acceptance of VIVO technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.